Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Ovarian Res ; 9(1): 43, 2016 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-27436085

RESUMO

BACKGROUND: The aim of this study was to evaluate HE4, CA125 and ROMA in the preoperative differentiation benign ovarian diseases from epithelial ovarian cancer depending on the menopausal status. METHODS: In order to estimate markers' concentrations in the serum of women with benign ovarian disease (n = 128) and with epithelial ovarian carcinoma (n = 96) the electrochemiluminescence (ECLIA) technique has been applied. RESULTS: Using the ROC analysis, although no statistical differences were found among their AUCs, the ROMA algorithm seems to be effective in gathering the diverse performance of HE4 and CA125. The AUC for HE4, CA125 and ROMA for all patients were: 0.895; 0.879 and 0.918, respectively. At established new optimal cutoff values for HE4, CA125 and ROMA we found higher specificity in postmenopausal compared to premenopausal women (96.9 vs 89.8 % and 97.7 vs 84.1 % and 95.9 vs 89.1 %, respectively). The sensitivity of HE4 in pre- and postmenopausal women was similar (83.5 vs 83.8 %), while for CA125 was the highest in premenopausal women (87.0 vs 84.1 %). For HE4, CA125 and ROMA the negative predictive value was high (97.6, 93.9 and 94.4 %, respectively). CONCLUSIONS: The ROMA algorithm shows the best diagnostic performance to distinguish epithelial ovarian cancer from benign ovarian disease. We found the high specificity of HE4 and CA125 while differentiating ovarian benign diseases from epithelial ovarian cancer in postmenopausal women and the high sensitivity of CA125 in detecting epithelial ovarian cancer in premenopausal patients.


Assuntos
Doenças dos Anexos/sangue , Doenças dos Anexos/diagnóstico , Algoritmos , Antígeno Ca-125/sangue , Proteínas de Membrana/sangue , Proteínas/análise , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/sangue , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Pós-Menopausa/sangue , Pré-Menopausa/sangue , Período Pré-Operatório , Proteína 2 do Domínio Central WAP de Quatro Dissulfetos
2.
Przegl Lek ; 72(7): 354-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26817348

RESUMO

Recent decades have brought significant progress in understanding the role of cytokines in many aspects of the development of periodontal disease associated with systemic disorders and increased risk of oral cancer. A thorough search of articles was carried out on the databases PubMed on the association of periodontal disease and obstetric pathologies, systemic diseases and cancer. Refs cited are examples of support already common idea that periodontal disease may affect the initiation and/or development of serious pathological conditions. Drawn from the literature review findings confirm that chronic untreated periodontal inflammatory processes have their own important part in promoting systemic diseases and also are associated with an increased risk of developing cancer diseases.


Assuntos
Citocinas/fisiologia , Inflamação/imunologia , Doenças Periodontais/complicações , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/imunologia , Diabetes Mellitus/etiologia , Diabetes Mellitus/imunologia , Feminino , Humanos , Neoplasias/etiologia , Neoplasias/imunologia , Gravidez , Complicações na Gravidez/etiologia , Complicações na Gravidez/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA